CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Percutaneous nephrostomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03936673
NCT03936673N/ACompleted

The Effect of Percutaneous Nephrostomy Application on Obstructed Kidneys With Relative Function of 10% or Less In Technetium-99m Dimercaptosuccinic Acid (DMSA) Scintigraphy

TC Erciyes University·interventional·Posted May 3, 2019·Updated May 3, 2019

In Brief

A clinical study evaluating Percutaneous nephrostomy for Obstructive Uropathy. Completed, enrolled 18 participants across 1 site.

Detailed Summary

Urinary tract obstruction is a serious health problem due to kidney damage. Relative renal function has an important role in the treatment of obstructed kidneys. Nephrectomy can be recommended when the relative renal function is 10% or less in radionuclide examinations. Recently, however, nephron sparing approaches have come to the fore. This indicated the need to evaluate the possibility of recovering the function of the kidney before nephrectomy. The aim of this study is to compare relative functions of obstructed kidneys in technetium 99m dimercaptosuccinic acid scintigraphy (DMSA) before and 2 weeks after nephrostomy tube.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 3, 2019
Enrollment StartJul 1, 2014
Primary CompletionMay 31, 2018
Study CompletionJan 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 7.2 years ago

Interventions

Percutaneous nephrostomyprocedure